Dr Philip M Hutchison, DO | |
112 Independence Way, Suite 120, Bellevue, OH 44811 | |
(419) 483-6655 | |
(419) 483-6699 |
Full Name | Dr Philip M Hutchison |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 112 Independence Way, Bellevue, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538138706 | NPI | - | NPPES |
0930818 | Medicaid | OH | |
P0064055 | Other | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 34005766 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Philip M Hutchison, DO Po Box 378, Sandusky, OH 44871-0378 Ph: (419) 609-1112 | Dr Philip M Hutchison, DO 112 Independence Way, Suite 120, Bellevue, OH 44811 Ph: (419) 483-6655 |
News Archive
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.
Adolescents who diet and develop disordered eating behaviors (unhealthy and extreme weight control behaviors and binge eating) carry these unhealthy practices into young adulthood and beyond, according to a study conducted by University of Minnesota researchers and published in the July 2011 issue of the Journal of the American Dietetic Association.
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
› Verified 5 days ago
Todd R Tamlyn, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 102 Commerce Park Dr Ste D, Bellevue, OH 44811 Phone: 419-483-2494 |